Induction of varicella-zoster virus-neutralizing antibodies in mice by co-infection with recombinant vaccinia viruses expressing the gH or gL gene

References

1. Boyle D. B., Coupar B. E. 1988; A dominant selectable marker for the construction of recombinant poxviruses. Gene 65:123–128
   [Google Scholar]
2. Davison A. J., Scott J. E. 1986; The complete DNA sequence of varicella-zoster virus. Journal of General Virology 67:1759–1816
   [Google Scholar]
3. Ecker J. R., Hyman R. W. 1982; Varicella zoster virus DNA exists as two isomers. Proceedings of National Academy of Sciences, USA 79:156–160
   [Google Scholar]
4. Forghani B., Dupuis K. W., Schmidt N. J. 1984; Varicellazoster viral glycoproteins analyzed with monoclonal antibodies. Journal of Virology 52:55–62
   [Google Scholar]
5. Forghani B., Ni L., Grose C. 1994; Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology 199:458–462
   [Google Scholar]
6. Gompels U. A., Minson A. C. 1986; The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology 153:230–247
   [Google Scholar]
7. Gompels U. A., Carss A. L., Saxby C., Hancock D. C., Forrester A., Minson A. C. 1991; Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H. Journal of Virology 65:2393–2401
   [Google Scholar]
8. Grose C., Edwards D. P., Friedrichs W. E., Weigle K. A., McGuire W. L. 1983; Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infection and Immunity 40:381–388
   [Google Scholar]
9. Hutchinson L., Browne H., Wargent V., Davis-Poynter N., Primorac S., Goldsmith K., Minson A. C., Johnson D. C. 1992; A novel herpes simplex virus glycoprotein, gl, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. Journal of Virology 66:2240–2250
   [Google Scholar]
10. Joklik W. K. 1962; The purification of four strains of poxvirus. Virology 18:9–10
    [Google Scholar]
11. Kaye J. F., Gompels U. A., Minson A. C. 1992; Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. Journal of General Virology 73:2693–2698
    [Google Scholar]
12. Keller P. M., Neff B. J., Ellis R. W. 1984; Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. Journal of Virology 52:293–297
    [Google Scholar]
13. Klupp B., Baumeister J., Karger A., Visser N., Mettenleiter T. 1994; Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL. Journal of Virology 68:3868–3878
    [Google Scholar]
14. Kunke D., Broucek J., Kutinová L., Němečková S., Ludvíková V., Strnad I., Kramosil J., Nemcova J., Schramlova J., Simonova V. 1993; Vaccinia virus recombinants co–expressing hepatitis B virus surface and core antigens. Virology 195:132–139
    [Google Scholar]
15. Kutinová L., Ludvíková V., Simonova V., Otavova M., Kryštofová J., Hainz P., Press M., Kunke D., Vonka V. 1995; Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine 13:487–493
    [Google Scholar]
16. Liu D. X., Gompels U. A., Foa–Tomasi L., Campadelli–Fiume G. 1993; Human herpesvirus–6 glycoprotein H and L homologs are components of the gplOO complex and the gH external domain is the target for neutralizing monoclonal antibodies. Virology 197:12–22
    [Google Scholar]
17. Ludvíková V., Kunke D., Hamšíková E., Kutinová L., Vonka V. 1991; Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant. Journal of General Virology 72:1445–1449
    [Google Scholar]
18. McGeoch D. J., Dalrymple M. A., Davison A. J., Dolan A., Frame M. C., Mcnab D., Perry L. J., Scott J. E., Taylor P. 1988; The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. Journal of General Virology 69:1531–1574
    [Google Scholar]
19. Mackett M., Smith G. L., Moss B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
    [Google Scholar]
20. Montalvo E. A., Grose C. 1986; Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Virology 149:230–241
    [Google Scholar]
21. Perkus M. E., Panicali D., Mercer S., Paoletti E. 1986; Insertion and deletion mutants of vaccinia virus. Virology 152:285–297
    [Google Scholar]
22. Schmidt N. J., Lennette E. 1976; Improved yields of cell-free varicella-zoster virus. Infection and Immunity 14:709–715
    [Google Scholar]
23. Sugano T., Tomiyama T., Matsumoto Y., Sasaki S., Kimura T., Forghani B., Masuho Y. 1991; A human monoclonal antibody against varicella-zoster virus glycoprotein III. Journal of General Virology 722065–2073
    [Google Scholar]